1. Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer;Attard;Cancer Res.,2009
2. Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays;Bubendorf;Cancer Res.,1999
3. Glucocorticoids manifest androgenic activity in a cell line derived from a metastatic prostate cancer;Chang;Cancer Res.,2001
4. Molecular determinants of resistance to antiandrogen therapy;Chen;Nat. Med.,2004
5. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone;Culig;Mol. Endocrinol.,1993